Global Oxaliplatin Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oxaliplatin market size will reach 1,262.95 Million USD in 2025 and is projected to reach 2,295.41 Million USD by 2032, with a CAGR of 8.91% (2025-2032). Notably, the China Oxaliplatin market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oxaliplatin is a platinum-based chemotherapy drug used in the treatment of various cancers, primarily colorectal cancer. It belongs to a class of medications known as platinum-containing compounds and works by interfering with the DNA in cancer cells, preventing their replication and ultimately leading to their destruction. Oxaliplatin is typically administered intravenously and is often used in combination with other chemotherapy drugs as part of a treatment regimen determined by a healthcare provider. While it can be effective in treating cancer, it may also have side effects, including peripheral neuropathy, nausea, and fatigue, which can vary in intensity and duration depending on the individual and treatment plan.
The major global suppliers of Oxaliplatin include Sanofi-Aventis, Yakult honsha, Dr Reddy＇s laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Nanjing Pharmaceutical Factory, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Chiatai Tianqing, Jari Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oxaliplatin. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oxaliplatin market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oxaliplatin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oxaliplatin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oxaliplatin Include:
Sanofi-Aventis
Yakult honsha
Dr Reddy＇s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Nanjing Pharmaceutical Factory
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Chiatai Tianqing
Jari Pharmaceutical
Oxaliplatin Product Segment Include:
Mannitol
Glucose Solution
Lactose Solution
Others
Oxaliplatin Product Application Include:
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oxaliplatin Industry PESTEL Analysis
Chapter 3: Global Oxaliplatin Industry Porter's Five Forces Analysis
Chapter 4: Global Oxaliplatin Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oxaliplatin Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oxaliplatin Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oxaliplatin Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oxaliplatin market size will reach 1,262.95 Million USD in 2025 and is projected to reach 2,295.41 Million USD by 2032, with a CAGR of 8.91% (2025-2032). Notably, the China Oxaliplatin market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oxaliplatin is a platinum-based chemotherapy drug used in the treatment of various cancers, primarily colorectal cancer. It belongs to a class of medications known as platinum-containing compounds and works by interfering with the DNA in cancer cells, preventing their replication and ultimately leading to their destruction. Oxaliplatin is typically administered intravenously and is often used in combination with other chemotherapy drugs as part of a treatment regimen determined by a healthcare provider. While it can be effective in treating cancer, it may also have side effects, including peripheral neuropathy, nausea, and fatigue, which can vary in intensity and duration depending on the individual and treatment plan.
The major global suppliers of Oxaliplatin include Sanofi-Aventis, Yakult honsha, Dr Reddy＇s laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Qilu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Nanjing Pharmaceutical Factory, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Chiatai Tianqing, Jari Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oxaliplatin. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oxaliplatin market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oxaliplatin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oxaliplatin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oxaliplatin Include:
Sanofi-Aventis
Yakult honsha
Dr Reddy＇s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Nanjing Pharmaceutical Factory
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Chiatai Tianqing
Jari Pharmaceutical
Oxaliplatin Product Segment Include:
Mannitol
Glucose Solution
Lactose Solution
Others
Oxaliplatin Product Application Include:
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oxaliplatin Industry PESTEL Analysis
Chapter 3: Global Oxaliplatin Industry Porter's Five Forces Analysis
Chapter 4: Global Oxaliplatin Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oxaliplatin Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oxaliplatin Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oxaliplatin Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oxaliplatin Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oxaliplatin Product by Type
- 1.2.1 Mannitol
- 1.2.2 Glucose Solution
- 1.2.3 Lactose Solution
- 1.2.4 Others
- 1.3 Oxaliplatin Product by Application
- 1.3.1 Colorectal Cancer
- 1.3.2 Stomach Cancer
- 1.3.3 Ovarian Cancer
- 1.3.4 Others
- 1.4 Global Oxaliplatin Market Size Analysis (2020-2032)
- 1.5 Oxaliplatin Market Development Status and Trends
- 1.5.1 Oxaliplatin Industry Development Status Analysis
- 1.5.2 Oxaliplatin Industry Development Trends Analysis
- 2 Oxaliplatin Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oxaliplatin Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oxaliplatin Market Analysis by Country
- 4.1 Global Oxaliplatin Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oxaliplatin Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oxaliplatin Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oxaliplatin Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oxaliplatin Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oxaliplatin Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oxaliplatin Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oxaliplatin Market Analysis by Type
- 6.1 Global Oxaliplatin Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oxaliplatin Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sanofi-Aventis
- 7.1.1 Sanofi-Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sanofi-Aventis Oxaliplatin Product Portfolio
- 7.1.3 Sanofi-Aventis Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Yakult honsha
- 7.2.1 Yakult honsha Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Yakult honsha Oxaliplatin Product Portfolio
- 7.2.3 Yakult honsha Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Dr Reddy＇s laboratories
- 7.3.1 Dr Reddy＇s laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Dr Reddy＇s laboratories Oxaliplatin Product Portfolio
- 7.3.3 Dr Reddy＇s laboratories Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Sun Pharmaceutical
- 7.4.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sun Pharmaceutical Oxaliplatin Product Portfolio
- 7.4.3 Sun Pharmaceutical Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Teva
- 7.5.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Teva Oxaliplatin Product Portfolio
- 7.5.3 Teva Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Fresenius Kabi
- 7.6.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Fresenius Kabi Oxaliplatin Product Portfolio
- 7.6.3 Fresenius Kabi Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Hospira
- 7.7.1 Hospira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Hospira Oxaliplatin Product Portfolio
- 7.7.3 Hospira Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Mylan
- 7.8.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Mylan Oxaliplatin Product Portfolio
- 7.8.3 Mylan Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Jiangsu Hengrui Medicine
- 7.9.1 Jiangsu Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio
- 7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Qilu Pharmaceutical
- 7.10.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Qilu Pharmaceutical Oxaliplatin Product Portfolio
- 7.10.3 Qilu Pharmaceutical Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Jiangsu Aosaikang Pharmaceutical
- 7.11.1 Jiangsu Aosaikang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio
- 7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Nanjing Pharmaceutical Factory
- 7.12.1 Nanjing Pharmaceutical Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio
- 7.12.3 Nanjing Pharmaceutical Factory Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Hisun Pharmaceutical
- 7.13.1 Hisun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Hisun Pharmaceutical Oxaliplatin Product Portfolio
- 7.13.3 Hisun Pharmaceutical Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Lunan Pharmaceutical
- 7.14.1 Lunan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Lunan Pharmaceutical Oxaliplatin Product Portfolio
- 7.14.3 Lunan Pharmaceutical Oxaliplatin Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Luoxin
- 7.15.1 Luoxin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Luoxin Oxaliplatin Product Portfolio
- 7.15.3 Luoxin Oxaliplatin Market Data Analysis (Revenue, Gross Margin and M
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
